The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers

Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer

The Role of Oncolytic Viruses in the Treatment of Melanoma

Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells

Integrating oncolytic viruses in combination cancer immunotherapy

Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo

Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells

Recurrent Glioblastoma Treated with Recombinant Poliovirus

Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus